Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, replacing the previous version identifier. This signals an internal update to the site’s template or CMS rather than changes to visible content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing v3.6.3. This indicates a newer page revision and likely minor updates to the record without changing the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s revision metadata includes a new revision entry (v3.6.2) with dates 2026-06-22 and 2028-06-30, and older revision markers (v3.6.0) along with several prior date entries are removed or updated. This reflects version-tracking adjustments rather than changes to the study details or disclosures.SummaryDifference0.4%

- Check74 days agoChange DetectedRecruitment status changed to No longer looking for participants, and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check81 days agoChange DetectedA revision label on the page was updated from v3.5.4 to v3.5.5, indicating a backend or content management system update for the entry.SummaryDifference0.1%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.